Revolution Medicines Statistics
Total Valuation
RVMD has a market cap or net worth of $5.82 billion. The enterprise value is $4.05 billion.
| Market Cap | 5.82B |
| Enterprise Value | 4.05B |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RVMD has 164.69 million shares outstanding. The number of shares has increased by 40.34% in one year.
| Shares Outstanding | 164.69M |
| Shares Change (YoY) | +40.34% |
| Shares Change (QoQ) | +3.59% |
| Owned by Insiders (%) | 2.46% |
| Owned by Institutions (%) | 96.14% |
| Float | 160.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 502.46 |
| Forward PS | 852.78 |
| PB Ratio | 3.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 349.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.06, with a Debt / Equity ratio of 0.05.
| Current Ratio | 13.06 |
| Quick Ratio | 12.91 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,450.79 |
Financial Efficiency
Return on equity (ROE) is -38.40% and return on invested capital (ROIC) is -25.45%.
| Return on Equity (ROE) | -38.40% |
| Return on Assets (ROA) | -33.60% |
| Return on Capital (ROIC) | -25.45% |
| Revenue Per Employee | $30,635 |
| Profits Per Employee | -$1.15M |
| Employee Count | 378 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.52M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.21% in the last 52 weeks. The beta is 1.54, so RVMD's price volatility has been higher than the market average.
| Beta (1Y) | 1.54 |
| 52-Week Price Change | +53.21% |
| 50-Day Moving Average | 32.15 |
| 200-Day Moving Average | 28.42 |
| Relative Strength Index (RSI) | 56.08 |
| Average Volume (30 Days) | 1,461,416 |
Short Selling Information
The latest short interest is 12.49 million, so 7.59% of the outstanding shares have been sold short.
| Short Interest | 12.49M |
| Short Previous Month | 12.00M |
| Short % of Shares Out | 7.59% |
| Short % of Float | 7.77% |
| Short Ratio (days to cover) | 7.78 |
Income Statement
In the last 12 months, RVMD had revenue of $11.58 million and -$436.37 million in losses. Loss per share was -$3.86.
| Revenue | 11.58M |
| Gross Profit | 11.58M |
| Operating Income | -487.19M |
| Pretax Income | -439.89M |
| Net Income | -436.37M |
| EBITDA | -430.28M |
| EBIT | -439.59M |
| Loss Per Share | -$3.86 |
Balance Sheet
The company has $1.86 billion in cash and $87.94 million in debt, giving a net cash position of $1.77 billion or $10.74 per share.
| Cash & Cash Equivalents | 1.86B |
| Total Debt | 87.94M |
| Net Cash | 1.77B |
| Net Cash Per Share | $10.74 |
| Equity / Book Value | 1.83B |
| Book Value Per Share | 11.09 |
| Working Capital | 1.74B |
Cash Flow
In the last 12 months, operating cash flow was -$350.57 million and capital expenditures -$7.73 million, giving a free cash flow of -$358.30 million.
| Operating Cash Flow | -350.57M |
| Capital Expenditures | -7.73M |
| Free Cash Flow | -358.30M |
| FCF Per Share | -$3.17 |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,207.12% and -3,768.28%.
| Gross Margin | 100.00% |
| Operating Margin | -4,207.12% |
| Pretax Margin | -3,798.71% |
| Profit Margin | -3,768.28% |
| EBITDA Margin | -3,715.71% |
| EBIT Margin | -3,796.10% |
| FCF Margin | -3,094.14% |
Dividends & Yields
RVMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.34% |
| Shareholder Yield | -40.34% |
| Earnings Yield | -7.50% |
| FCF Yield | -6.16% |
Analyst Forecast
The average price target for RVMD is $41.64, which is 17.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.64 |
| Price Target Difference | 17.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 119.83% |
| EPS Growth Forecast (5Y) | -8.18% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RVMD has an Altman Z-Score of 14.36 and a Piotroski F-Score of 2.
| Altman Z-Score | 14.36 |
| Piotroski F-Score | 2 |